Loading clinical trials...
Loading clinical trials...
A Phase II Study to Evaluate the Effect of Dalteparin and Radiation Therapy on Survival Compared to the RTOG RPA Database and on Thromboembolic Events in Patients With Newly Diagnosed Glioblastoma Multiforme
Conditions
Interventions
dalteparin
radiation therapy
Locations
12
United States
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
CCOP - Carle Cancer Center
Urbana, Illinois, United States
CCOP - Kalamazoo
Kalamazoo, Michigan, United States
West Michigan Cancer Center
Kalamazoo, Michigan, United States
Mayo Clinic Cancer Center
Rochester, Minnesota, United States
CCOP - Metro-Minnesota
Saint Louis Park, Minnesota, United States
Start Date
July 11, 2002
Primary Completion Date
July 1, 2006
Completion Date
June 1, 2007
Last Updated
June 18, 2023
NCT00602667
NCT00978458
NCT00683319
NCT07416188
NCT00897286
NCT06742593
Lead Sponsor
Eastern Cooperative Oncology Group
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions